Four tickers, chosen to be unlike each other: a biotech holding company, a diversified miner, a government-software compounder, and the most argued-about megacap on earth. The instruction was to run the five-factor model across all four and name the ikar. The instruction contains a trap, and the trap is the interesting part.
The brief, as sent:
“These are 4 totally different stocks….. Let’s see how well she does without additional training.”
Correct on the first count. That is precisely why they cannot share one instrument.
The Return Engine already settled this, in its own words: “The master’s first move is classification, not calculation… Classification is the gate; calculation is the path beyond it.” It shipped a domain map of eight archetypes showing where each of the five factors is meaningful, corrupted, or undefined.
These four names land in four different cells of that map. So running one bridge across all four would not merely be imprecise — on two of them the model, in the document’s own phrasing, “would have actively misled you.” The answer to the test is therefore not four bridges. It is one gate, then four instruments.
- TYL — the engine applies cleanly. It is the only one of the four that does.
- RIO — one factor survives; the other four are cycle artifacts.
- TSLA — four factors are negative and the fifth is a belief; the engine describes roughly a tenth of the market capitalisation.
- FBIO — the engine is silent. Waterfall and clock instead.
Everything below is traced to primary filings pulled for this exercise. Where a figure could not be verified twice, it is flagged rather than smoothed over.
Part One
Rule Two — the Ikar
The most valuable item on the list, and the one most easily skipped.
Rule two arrived as “what is the iker.” Read it as עיקר — ikar: the essence, the main thing, the point on which everything actually turns. Its counterpart is טפל — tafel: the peripheral, the material that looks important and is not.
That distinction is not a finance term, and it is worth more than most finance terms. A five-factor bridge produces five numbers; the ikar demands you say which single variable the outcome hinges on, and then rank everything else beneath it. A thesis without an ikar is a list. A thesis with one is a bet.
The disciplineעיקר · טפל
One sentence. One variable. If that variable moves against you, the thesis is wrong — and no amount of accuracy in the other four factors saves it.
Applied below to each name, in the same shape every time: the ikar stated in one sentence, then the tafel — the things that will occupy most of the commentary and most of the quarterly noise, and that will not decide the outcome.
It also disciplines the model itself. For three of these four companies, the ikar sits outside the five factors entirely — in a commodity price, in a capital structure, in a regulatory approval. That is the tell that you have reached for the wrong instrument.
Part Two
The Classification Gate
Where each of the four sits on the domain map — and which instrument that dictates.
The Return Engine’s own matrix, with the four names placed. Note that no two share a row.
| Archetype | Meaningful factors | Corrupted / undefined | Primary tool |
|---|---|---|---|
| Mature industrials / staples | All five | None | DCF / five-factor model |
| High-growth compounders→ TYL | Revenue growth, multiple change; margin trajectory as swing factor | Dividend, net buyback (no longer true at Tyler — see Part Three) | DCF, long duration |
| Banks / insurers | Net buyback, multiple change (P/B) | Revenue growth, margin change | Book value, ROE, P/B |
| Commodities / deep cyclicals→ RIO | Dividend, net buyback (only in upcycle) | Revenue growth, margin change, multiple change (spot multiples are noise) | Normalized mid-cycle earnings |
| REITs | Dividend (as FFO payout) | Revenue growth, margin change | FFO / AFFO, NAV |
| Holding cos / conglomerates→ FBIO | Dividend (from subsidiaries), net buyback (parent level) | Revenue growth, margin change (consolidated financials blend unlike businesses) | SOTP / NAV |
| Pre-revenue / optionality→ TSLA (≈90% of cap) · FBIO | None | All five undefined | rNPV, SOTP of pipeline |
| Distressed / sub-liquidation→ FBIO (floor test) | None | All five corrupted — value depends on capital structure | Asset value, liquidation waterfall |
FBIO occupies three rows at once — a holding company, containing optionality, tested against a liquidation floor. That is not indecision; it is the finding.
One name lands in the engine’s home territory. One lands where only the dividend survives. One is a composite whose priced value sits almost entirely in a cell where all five factors are undefined. One is in three broken cells simultaneously.
Whether by design or by instinct, the four-stock test is a classification exam wearing a calculation costume.
Part Three
Tyler Technologies
The one name where the engine runs without adjustment.
40.95m shares · 8/10/2026
Software sold to US state and local government: courts, public safety, property records, payments. Fifty thousand mission-critical installations across sixteen thousand client locations — roughly 11% of a ~500,000-installation market — with 98% client retention and contracts that auto-renew on three-to-five year terms. A county does not rip out its court record system.
The matrix files high-growth compounders under “dividend and buyback negligible.” That has stopped being true, and it is the most important thing about the name right now. Tyler repurchased 5.6% of its shares in the first half of 2026 alone, with $1.745bn of authorization remaining against a $13.0bn market capitalisation — a further 13%. Capital return has gone from a rounding error to the second-largest term in the bridge.
That migration matters: a compounder crossing into cash-machine territory is precisely when the five-factor model stops being a stretch and becomes the correct instrument.
| Factor | Current | Forward est. | Confidence | Expected contribution |
|---|---|---|---|---|
| D dividend | 0.0% | 0.0% | No dividend, by policy | 0.00% |
| B buyback | +6.9% | +4.0% | 85% — FCF yield 5.3%, less SBC | 3.40% |
| G revenue | +9.1% | +9.5% | 80% — ARR $2.24bn, SaaS +21.7% | 7.60% |
| M margin | −6.5% | +3.0% | 60% — cloud drag reverses | 1.80% |
| X multiple | 40.7× / 21.8× fwd | 0.0% | Not required | 0.00% |
| Expected total return | ≈ 12.8% |
M is currently negative — net margin 13.4% against 14.3% a year ago — because cloud hosting, implementation and elevated R&D are being expensed through the transition. Management’s 2030 targets are non-GAAP gross margin 59–60%, operating margin mid-30s, FCF margin low-30s against 26–28% guided for 2026. The drag is the investment.
Independent cross-check. Tyler’s stated 2030 free cash flow target is $1.1–1.2bn. Against today’s $13.05bn capitalisation that is an 8.4–9.2% forward FCF yield, arrived at with no multiple assumption at all, while the share count shrinks. A second route to the same mid-teens conclusion.
The Ikar · TYLעיקר
Switching costs in a government system of record — not growth rate, not the multiple. A jurisdiction that has embedded its courts, its property roll and its payments in Tyler cannot leave, so revenue converts to annuity and the only real question is what margin that annuity eventually earns.
Tafel: quarterly SaaS growth prints, individual acquisitions, the on-prem-to-cloud flip count, near-term GAAP EPS distorted by acquired-intangible amortisation. All noisy, none decisive.
| Your rule | Answer |
|---|---|
| 3 · Marginal buyer & seller | The marginal seller is a growth fund that capitulated when growth settled near 9% — the multiple fell from a reported ten-year average of 76.6× to 40.7×. The marginal buyer is now Tyler itself, retiring 5.6% of the float in six months. A company buying an eighth of itself is a structural bid. What changes it: hard evidence that the margin unlock is real, which brings quality/GARP money back. |
| 4 · Marginal returns on capital | GAAP ROIC ≈9% against a WACC of roughly 8% looks thin — but it is depressed by acquisition amortisation. Look at the margin instead: capex is $43.2m on $2.43bn of revenue (1.8% of sales), and an incremental SaaS conversion carries a target 59–60% gross margin. Incremental returns run far above average returns. That gap is the whole investment case. |
| 5 · Cyclical? Where? | Partially — best described as recurring/defensive with cyclical edges, not non-cyclical. 86.7% recurring revenue is budgeted and mission-critical; new implementations, payment volumes and procurement do slow with state and local budgets. Track: SaaS bookings (+12.5% YoY, a record), flip count (488 in 2025), recurring mix against the 90% target. |
| 6 · Management alignment | Aligned in behaviour: no dividend, aggressive repurchase, and public multi-year targets that can be scored against. Precise insider ownership was not verified — flagged, not guessed. |
| 7 · Upside optionality — valued? | Payments/transaction revenue and the eventual >90% recurring mix at mid-30s operating margin. A forward P/E of 21.8× says the market credits part of it. The unpriced piece is consolidation: 11% share of a fragmented 500,000-installation market. |
The engine’s home turf, and the only clean five-factor name of the four. Its expected return is built from the persistent terms — buyback, growth, margin — and needs no re-rating to work. Of the four, this is the highest-quality return stream and the one the model was actually designed to measure.
Part Four
Rio Tinto
One factor survives. The other four are cycle artifacts wearing precision.
net debt $14.4bn · 8/11/2026
A diversified miner in name; an iron ore company in economics. Iron ore produced $15.2bn of $27.1bn segment EBITDA in 2025 — 56%, with copper at 27% and aluminium and lithium at 17%. The marginal dollar of value still comes from a single price print delivered into China.
The matrix is blunt here: for deep cyclicals only dividend and buyback carry information, and spot multiples are noise. Run the bridge anyway and you get the classic cyclical inversion.
| Factor | Reported | Status | Why |
|---|---|---|---|
| D dividend | 3.98% | Meaningful | 402c for FY2025 at a 60% payout — held for ten consecutive years against a stated 40–60% through-cycle policy. Real, but a residual of an exogenous price, not a floor. The H1-2026 interim stepped down to 50%. |
| B buyback | ≈0% | Absent | No material repurchase identified. Meaningful in an upcycle and conspicuously missing — the cash is going to Simandou instead. Its absence is the signal. |
| G revenue | +7.4% | Corrupted | Price × volume where price is exogenous. The three-year CAGR is 1.2% and volumes are broadly flat; the TTM figure is a commodity print, not growth. |
| M margin | 20.5% (−1.0pp) | Corrupted | Margin here is a derivative of the iron ore price, not operating leverage. It tells you what the commodity did, which you already knew. |
| X multiple | 13.5× | Corrupted | The trap. TTM underlying EBITDA of $28.7bn sits ~22% above the 2016–2025 median of $23.6bn. Normalise earnings to mid-cycle and the multiple becomes ≈16.5×. A low P/E on above-mid-cycle earnings is the sell signal, not the buy signal. |
Cycle read: upper-mid, not trough. TTM EBITDA $28.7bn against $23.3bn in 2024 and $25.4bn in 2025; H1-2026 EBITDA rose 28% to $14.8bn on copper and aluminium strength. But iron ore averaged $105/t in H1 and fell 8% through Q2 to roughly $95/t, against a ten-year average near $105 and a five-year range of about $80–220.
Then the part that deserves more attention than it gets. Simandou. Sixty million tonnes a year of new capacity, Rio’s share 27Mtpa, $11.6bn of total capital with $6.2bn on Rio’s side, first shipment December 2025 and a thirty-month ramp to full rate.
It is a fine orebody. It is also, unavoidably, new seaborne supply delivered into the market that sets the price of the asset generating 56% of Rio’s profit. The company’s largest growth project works against its own realised price. That tension is the investment case, and it is rarely stated plainly.
The Ikar · RIOעיקר
The 62% Fe price into China — nothing else is close. Chinese steel and property demand set it, Australian, Brazilian and now Guinean supply meet it, and Rio is adding to that supply itself.
Tafel: the copper ramp (genuinely good — 26% divisional ROCE), aluminium, the lithium build, cost programmes, leadership changes. All real, none decisive against a 56% profit concentration in one commodity.
| Your rule | Answer |
|---|---|
| 3 · Marginal buyer & seller | Income funds and cyclical rotators own the equity, but they are not setting the price — the Chinese steel mill is. The marginal buyer of the product determines the marginal buyer of the share. What changes it: Chinese property and stimulus, and the Simandou ramp adding supply from the other side. |
| 4 · Marginal returns on capital | The sharpest finding here. FY2025 underlying ROCE was 18%, and H1-2026 divisional ROCE was 29% iron ore, 26% copper, 21% aluminium — and 2% lithium. Capital is being redirected out of a 29% business into projects earning materially less, including over $1bn a year into lithium at 2%. Marginal ROIC sits far below average ROIC. That is a value transfer, whatever the strategic logic. |
| 5 · Cyclical? Where? | Deeply cyclical, and currently upper-mid rather than trough — which is exactly when a cyclical looks statistically cheapest and is not. Track: 62% Fe CFR China, Chinese steel output and property starts, Pilbara unit cash cost ($23.5/wet tonne), and the Simandou ramp schedule. |
| 6 · Management alignment | Ten consecutive years at a 60% payout is genuine shareholder orientation. The H1-2026 step down to 50% while capex runs at $11bn is the thing to watch: capital is quietly shifting from owners to projects. Insider ownership not verified. |
| 7 · Upside optionality — valued? | Copper is the real option — Oyu Tolgoi underground complete, Resolution and Winu behind it — and it is partly priced. Lithium at a 2% return is not optionality; on current evidence it is a drag wearing optionality’s clothing. |
One factor survives, and it is a residual of a price nobody at Rio controls. Normalised to mid-cycle the stock is roughly 16.5× — not the 13.5× on the screen. Own it for the dividend and the copper, size it for the iron ore, and do not mistake a cyclical peak multiple for value.
Part Five
Tesla
Four factors negative. The fifth is a belief.
3,950m shares · 8/12/2026
The Return Engine’s line on Fortress was that four of five factors are corrupted and the fifth is a cost. Tesla produces the mirror image, and it is worth stating in the same shape: four of five factors are negative, and the fifth is a belief.
| Factor | Trailing twelve months | Reading |
|---|---|---|
| D dividend | 0.0% | None, and none contemplated. |
| B buyback | ≈ −12% p.a. | Negative, and materially so. Issued shares went 3,216m at end-2024 → 3,751m at end-2025 → ~3,950m now. On the model’s own definition (−Δ ln S) that is roughly −20% cumulative. Much of it is the 2025 CEO award rather than ordinary operating dilution — but the dilution lands on holders either way. |
| G revenue | −2.9% | TTM revenue of $103.6bn shrank. Q2-2026 automotive revenue did rebound +23% year on year off a weak base, so the trend is improving — but the twelve-month print is negative. |
| M margin | −8.6% | Net margin 3.67% against 4.00%. Automotive gross margin excluding credits is 16.3%, down 2.9pp both year on year and sequentially. And regulatory credits — near-pure margin — collapsed to $146m in Q2-2026 from $439m, after the July 2025 elimination of CAFE non-compliance penalties removed the reason to buy them. |
| X multiple | 306× vs 170× 10-yr median | Reversion to the ten-year median alone would be about −59%. The observed ten-year range runs from 31× to 1,397×, which is another way of saying this term carries no forecasting content at all. |
Free cash flow deserves a line of its own: $5.76bn across the TTM, but Q2-2026 free cash flow was negative $1,092m on quarterly capex of $5,789m. Capital intensity is rising sharply into AI compute, Optimus and autonomy.
Mechanically the bridge sums to something catastrophic. That answer should be discarded — not because it is arithmetically wrong, but because it answers a question almost nobody owning this stock is asking.
Here is the decisive calculation. Trailing operating income is $4.37bn. Capitalise the existing auto, energy and services business at a generous 20–30× and you get $87–131bn. Against a market capitalisation of roughly $1.31tn:
The entire five-factor apparatus describes about 7–10% of Tesla’s market capitalisation.
The other ~90% sits in a cell of the matrix where all five factors are, by definition, undefined. A published sell-side sum-of-the-parts splits it robotaxi 45%, Optimus 19%, FSD 17%, core auto 12%, energy 6% — contested in every direction, which is itself the point.
So the model is not misleading here in the way it misleads on Rio. It is simply silent on the thing that sets the price. The correct instrument is the one the matrix prescribes for optionality: risk-adjusted NPV and real options on autonomy, with the auto business valued separately as the funding base that keeps the option alive.
The Ikar · TSLAעיקר
Whether autonomy converts from narrative into cash flow before dilution, the loss of regulatory credits and Chinese competition erode the base that funds it. One question, roughly binary, on a long fuse.
Tafel: quarterly deliveries, average selling price, the next price cut — and, more surprisingly, even the energy business, which is the healthiest part of Tesla (29.8% FY2025 gross margin, 13.5 GWh deployed in Q2) and still only ~6% of the value on that sum-of-the-parts. Being right about energy and wrong about autonomy loses money.
| Your rule | Answer |
|---|---|
| 3 · Marginal buyer & seller | Price is set by retail conviction, thematic AI flows and passive index demand — by belief duration, not by cash flow. A 306× multiple is the longest-duration asset on the board, so it is also the most rate-sensitive. What changes the profile: verifiable robotaxi scale, any key-man or compensation event, and the rate path. |
| 4 · Marginal returns on capital | $12.9bn of TTM capex against $4.37bn of operating income, with the most recent quarter free-cash-flow negative. Marginal capital is going into autonomy, compute and robotics with no disclosed segment return. Marginal ROIC is not merely low — it is currently unmeasurable, and that is the honest finding. |
| 5 · Cyclical? Where? | The auto half is deeply cyclical and now genuinely competitive against BYD and the Chinese OEMs; FY2025 automotive revenue fell 9.8% before the Q2-2026 rebound. The optionality half is not cyclical at all — it is binary. Two different businesses on two different clocks. Track: automotive gross margin ex-credits, the credit run-off, storage GWh. |
| 6 · Management alignment | Incentive alignment is extreme by construction — and the 2025 award is itself the largest single cause of the share count rising ~23%. Alignment and dilution are the same transaction here. Exact current stake not verified. |
| 7 · Upside optionality — valued? | Rule 7 inverts. The optionality is not merely valued, it is roughly 90% of the price. The useful question is the opposite one: is anything else valued at all? On these numbers, barely. |
Do not run the engine here and report the answer — it describes a tenth of the asset. Tesla is a cyclical manufacturer stapled to a venture portfolio, and it must be valued as two things: a going concern worth roughly $90–130bn, plus an option on autonomy carrying everything else. Anyone quoting a P/E on this name, high or low, has already made the classification error.
Part Six
Fortress Biotech
The engine is silent — but the floor moved, and it moved upward.
Q1-2026 Form 10-Q
The Return Engine already dismantled this one: four of five factors corrupted, the fifth a cost. That holds, and the fresh pull sharpens it — the “dividend” term is a 9.375% Series A preferred, 3,427,138 shares at $25, an $85.68m liquidation preference accruing $8.03m a year, suspended since 5 July 2024 and cumulative. Not income. A senior claim compounding ahead of the common.
Buyback is likewise inverted: shares went 31,364,094 at end-2025 → 33,186,671 at 31 March → 33,219,072 at 11 May 2026. Roughly 6% dilution in five months.
But re-running the waterfall on primary sources turned up something the earlier note could not have known.
▪ Three corrections to the record
- The priority review voucher was a placeholder — and it is now realised. The prior working figure was $46.1m. Cyprium received a rare pediatric disease PRV on ZYCUBO’s approval (13 Jan 2026), agreed to sell it on 22 February, and collected $205m gross on 30 March 2026. Banked cash, not an estimate.
- Fortress → Journey ownership: 36.1% — one of the two figures the Return Engine deliberately left unsized. Now sourced.
- The 4.5% Founders Agreement net-sales fee: verified. The second open figure, closed.
The waterfall, rebuilt. Consolidated cash at 31 March 2026 was $255.8m — but consolidated is the wrong number, because it blends in cash belonging to minority holders of the listed subsidiaries. The filing breaks it out: $209.9m at the parent and private subsidiaries, $27.2m at Journey, $16.3m at Mustang, $2.4m at Avenue.
| Waterfall to common | USD m | Per share |
|---|---|---|
| Cash — parent & private subsidiaries | 209.9 | $6.32 |
| Less: notes payable (gross) | (40.0) | ($1.20) |
| Less: preferred liquidation preference | (85.7) | ($2.58) |
| Less: preferred accrued since Jul-2024 (≈2.1 yrs @ $8.03m) | (16.9) | ($0.51) |
| Cash-only floor to common | 67.3 | $2.03 |
Before any credit for the 36.1% Journey stake, Cyprium’s ZYCUBO royalties (3% / 8.75% / 12.5% tiers plus up to $128m of milestones), Helocyte, or the rest of the pipeline. On 33,219,072 shares.
Independent cross-check. This lands at $2.03 against the Return Engine’s ~$2.30 floor — reached by a different route, on newer filings, and now resting on realised cash rather than an estimated voucher. Two methods, one floor. That is the strongest thing you can say about a number.
And then the offset, which is where the real discipline lives. FY2025 operating cash flow was −$65.8m. On 33.2m shares that is $1.98 per share per year of burn — against a $2.03 floor.
The Ikar · FBIOעיקר
The clock, not the science. The floor is real and now built on banked cash — but it amortises at roughly $2.00 per share per year while the preferred accrues ahead of you. Value reaches the common only if a catalyst lands before the cash leaves. There is about twelve months of margin in that race.
Tafel: the breadth of the pipeline, individual trial designs, the subsidiary count. A development portfolio is only worth what the capital structure lets it deliver to the bottom of the stack — and there is $102.6m of senior claim between the assets and you.
| Your rule | Answer |
|---|---|
| 3 · Marginal buyer & seller | A 33.2m-share float traded by microcap and event-driven money. Price is set by liquidity and headlines, not by discounted cash flow — which is exactly why a floor calculation has any edge at all. What changes it: an Emrosi outcome, a ZYCUBO royalty print, or a financing that dilutes. |
| 4 · Marginal returns on capital | Negative at the parent by construction — Fortress funds development subsidiaries. But the model demonstrably works once: a programme carried to approval produced a $205m voucher. The parent’s structural take is the verified 4.5% net-sales fee on subsidiary revenue. That is the machine; the question is repeatability. |
| 5 · Cyclical? Where? | Not cyclical — event-driven and close to binary. There is no cycle to position within, only a runway to measure. Track: quarterly burn, ZYCUBO ramp, Emrosi ($6.3m in Q1-2026, ~85% commercial access), Helocyte Phase 2 topline due mid-2026. |
| 6 · Management alignment | Worth naming plainly: the 4.5% Founders fee pays the parent on subsidiary sales, not on returns to common holders. Those are not the same objective. Suspending the preferred conserves cash but forfeits S-3 shelf eligibility — a financing constraint that raises the cost of the next raise. |
| 7 · Upside optionality — valued? | Optionality is essentially all there is, and at these levels much of it is free. But it sits behind $102.6m of senior claims and a burn clock. Free optionality with a deadline is worth owning — in size proportional to the deadline. |
The engine stays silent; the waterfall does the work. The floor is firmer than the original note assumed — realised cash, not an estimated voucher — and two independent routes now agree near $2.00–$2.30. The prior conclusion stands unchanged: buy, small. The “small” was never about conviction. It is about the clock.
◆
The Scoreboard
Ranked by how much of the expected return depends on the least persistent term.
The Return Engine ranked the five factors by persistence: dividend most durable, multiple change least — “the least persistent, most volatile term in the equation.” Rank the four names by how much of their return needs X to cooperate, and the test answers itself.
| Name | Cell on the map | Correct instrument | Return rests on | |
|---|---|---|---|---|
| 1 | TYL | High-growth compounder, migrating to cash machine | Five-factor bridge — unadjusted | B + G + M. No re-rating required. The persistent terms do the work. |
| 2 | RIO | Deep cyclical | Normalized mid-cycle earnings | D only — and D is a residual of an exogenous price. ~16.5× mid-cycle, not 13.5×. |
| 3 | FBIO | Holding co · optionality · liquidation floor | SOTP, rNPV, waterfall | No factors at all. A discrete event against a burn clock, with a floor near $2.00. |
| 4 | TSLA | Composite: cyclical manufacturer + optionality | rNPV / real options, plus a separate going-concern value | X and belief — ~90% of the price. Lowest persistence on the board. |
Four names, four cells, four instruments. One bridge would have produced four confident numbers and three wrong ones.
The ranking also exposes something the raw bridges hide: TYL and TSLA are opposites, not neighbours. Tyler’s expected return comes almost entirely from the durable terms and needs no help from the multiple. Tesla’s rests almost entirely on the single term the model itself identifies as least persistent. They are not both “growth stocks.” They are structurally opposed.
The answer to rule two, for the exercise as a whole:
The ikar was never the five factors. It was knowing which of the four companies they were entitled to describe.
One of four. That is not a failure of the model — it is the model used correctly.
“Classification is the gate; calculation is the path beyond it.”
Verification Spine
Figures traced to primary sources pulled 12 Aug 2026: Tesla Q2-2026 Update and FY2025 10-K; Rio Tinto FY2025 results, H1-2026 release and SEC exhibits; Tyler Q2-2026 10-Q, Q2 release and June-2026 Investor Day; Fortress Q1-2026 10-Q and FY2025 10-K. Prices: TSLA $332.81, RIO $100.99 (8/11), TYL $318.63 (8/10). Reconfirm before transmission.
Two open items from the Return Engine are now closed: Fortress → Journey ownership is 36.1%, and the 4.5% Founders Agreement net-sales fee is verified. One figure is corrected: the PRV was carried at an estimated $46.1m; the voucher in fact sold for $205m gross, received 30 March 2026.
Deliberately unsized rather than guessed: Rio’s ten-year average P/E, China revenue share and buyback authorisation; Tyler’s net revenue retention and three-year share count; Tesla’s robotaxi fleet size, any separately disclosed autonomy revenue, and ROIC; Fortress’s live market price and subsidiary market caps. Vendor disagreements were recorded, not averaged away. The Tesla going-concern split is an illustrative sensitivity and is contested by every party who has attempted it.
On the test itself
Four totally different stocks was the right instinct, and it made for a better exam than a single-name deep dive would have. But the four differences are not differences of sector — they are differences of regime. A biotech holding company, a deep cyclical, a maturing compounder and a narrative composite each break the five-factor model in a different place, and the skill being tested is noticing where.
The framework here is yours. Every factor definition, the domain map, the persistence ranking and the discipline of naming an edge come from the Return Engine as written. What has been added is the gate applied four times, the arithmetic run against fresh filings, and an ikar named for each. No finance library, dataset, or specialist training was supplied for this — only your document and the primary filings pulled today. That is worth saying only because it makes a point the document itself makes better: the process is the portable part. Point it at any company and it works, because it does not depend on the company.